Log In
BCIQ
Print this Print this
 

Emerflu

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionFirst generation aluminum hydroxide adjuvanted H5N1 vaccine containing 30 ug of hemagglutinin per dose
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentApproved
Standard IndicationInfluenza virus
Indication DetailsVaccinate against pandemic influenza virus
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/08/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today